Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Doximity (DOCS) stocks in Canada

Learn how to easily invest in Doximity stocks.

Doximity Inc.
+ $1.66 ( + 4.89%)

Doximity is a health information services business based in the US. Doximity stocks (DOCS.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $48.32 – an increase of 7.48% over the previous week. Doximity employs 0 staff and has a trailing 12-month revenue of around $343.5 million.

How to buy stocks in Doximity

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DOCS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Doximity stock price (NYSE:DOCS)

Use our graph to track the performance of DOCS stocks over time.

Doximity shares at a glance

Information last updated 2022-05-20.
Latest market close$33.92
52-week range$27.06 - $107.79
50-day moving average $44.54
200-day moving average $60.46
Wall St. target price$50.15
PE ratio 46.4571
Dividend yield $0 (0%)
Earnings per share (TTM) $0.70

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Doximity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Doximity price performance over time

Historical closes compared with the close of $33.92 from 2022-05-26

1 week (2022-05-20) 7.48%
1 month (2022-04-27) -21.66%
3 months (2022-02-25) -42.58%
6 months (2021-11-26) -44.51%
1 year (2021-05-23) N/A
2 years (2020-05-23) N/A
3 years (2019-05-23) N/A
5 years (2017-05-23) N/A

Is Doximity under- or over-valued?

Valuing Doximity stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Doximity's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Doximity's P/E ratio

Doximity's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 46x. In other words, Doximity shares trade at around 46x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Doximity's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.

Doximity's EBITDA

Doximity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $118.8 million.

The EBITDA is a measure of a Doximity's overall financial performance and is widely used to measure a its profitability.

To put Doximity's EBITDA into context you can compare it against that of similar companies.

Doximity financials

Revenue TTM $343.5 million
Operating margin TTM 33.12%
Gross profit TTM $303.8 million
Return on assets TTM 11.44%
Return on equity TTM 30.15%
Profit margin 45.05%
Book value $4.59
Market capitalisation $6.2 billion

TTM: trailing 12 months

Doximity share dividends

We're not expecting Doximity to pay a dividend over the next 12 months.

You may also wish to consider:

Doximity overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site